Nano Mobile Healthcare Inc (VNTH)
0.0003
0.00 (0.00%)
USD |
OTCM |
Apr 18, 12:54
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.2410M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -71.43% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.99% |
Profile
| Nano Mobile Healthcare Inc engages in developing a platform technology that analyzes Volatile Organic Compound signatures in a person’s breath by using a handheld device providing immediate results. The company has identified two markets been the detection of lung cancer and the presence of marijuana in a driver’s breath. Its secondary device testing indications include forms of cancer, chronic diseases such as heart failure as well as or contagious diseases such as strep throat. Its sensor can be connected through Bluetooth to any capable smart device running an iOS or Android operating system. |
| URL | http://www.nanomobilehealthcare.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Consumer Discretionary |
| Industry | Specialty Retail |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Nano Mobile Healthcare Inc engages in developing a platform technology that analyzes Volatile Organic Compound signatures in a person’s breath by using a handheld device providing immediate results. The company has identified two markets been the detection of lung cancer and the presence of marijuana in a driver’s breath. Its secondary device testing indications include forms of cancer, chronic diseases such as heart failure as well as or contagious diseases such as strep throat. Its sensor can be connected through Bluetooth to any capable smart device running an iOS or Android operating system. |
| URL | http://www.nanomobilehealthcare.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Consumer Discretionary |
| Industry | Specialty Retail |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |